Uses and development of neurodefend for treating neurodegenerative diseases
US-11167000-B2 · Nov 9, 2021 · US
US9844575B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9844575-B2 |
| Application number | US-201414759471-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 10, 2014 |
| Priority date | Jan 10, 2013 |
| Publication date | Dec 19, 2017 |
| Grant date | Dec 19, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a pharmaceutical composition and a health functional food composition for prevention, treatment or amelioration of diabetic complications or angioedema containing a mixed extract of Hedera helix leaves and Coptis chinensis as an active ingredient. More specifically, the present invention relates to a pharmaceutical composition and a health functional food composition for prevention, treatment or amelioration of diabetic complications or angioedema further containing an extract of Rheum palmatum, Puerariae radix, Ginkgo leaves, Cassiae semen , blueberry, bilberry, raspberry, or grape seeds as an active ingredient, in addition to the mixed extract of Hedera helix leaves and Coptis chinensis.
Opening claim text (preview).
The invention claimed is: 1. A method of preventing or treating diabetic complications or angioedema, comprising administering a pharmaceutical composition to a subject in need thereof, wherein the composition comprises a mixed ethanol extract of Hedera helix leaves and Coptis chinensis as an active ingredient. 2. The method according to claim 1 , wherein the composition is prepared by mixing a Hedera helix leaf ethanol extract and a Coptis chinensis ethanol extract at a ratio of 10:1 to 1:10, or by mixing Hedera helix leaves and a Coptis chinensis at a ratio of 10:1 to 1:10, followed by ethanol extraction. 3. The method according to claim 1 , wherein the composition further comprises an extract of Rheum palmatum, Puerariae radix, Ginkgo leaves, Cassiae semen , blueberry, billberry, raspberry, or grape seeds. 4. The method according to claim 1 , wherein the composition further comprises metformin. 5. The method according to claim 1 , wherein the ethanol extraction is subject to reflux cooling extraction. 6. The method according to claim 1 , wherein the diabetic complication is diabetic ocular disease, diabetic retinopathy, diabetic cataract, diabetic nephropathy, diabetic neuropathy, diabetic cancer, diabetic heart disease, diabetic osteoporosis, or diabetic arteriosclerosis. 7. The method according to claim 1 , wherein the angioedema is varicose veins, macular edema, or macular degradation. 8. A method for preventing or ameliorating diabetic complications or angioedema, comprising administering a functional food composition to a subject in need thereof, wherein the food composition comprises a mixed ethanol extract of Hedera helix leaves and Coptis chinensis as an active ingredient. 9. The method according to claim 8 , wherein the composition is prepared by mixing a Hedera helix leaf ethanol extract and a Coptis chinensis ethanol extract at a ratio of 10:1 to 1:10, or by mixing Hedera helix leaves and a Coptis chinensis at a ratio of 10:1 to 1:10, followed by ethanol extraction. 10. The method according to claim 8 , wherein the composition further comprises an extract of Rheum palmatum, Puerariae radix, Ginkgo leaves, Cassiae semen , blueberry, billberry, raspberry, or grape seeds. 11. The method according to claim 8 , wherein the extraction is subject to reflux cooling extraction. 12. The method according to claim 8 , wherein the diabetic complication is diabetic ocular disease, diabetic retinopathy, diabetic cataract, diabetic nephropathy, diabetic neuropathy, diabetic cancer, diabetic heart disease, diabetic osteoporosis, or diabetic arteriosclerosis. 13. The method according to claim 8 , wherein the angioedema is varicose veins, macular edema, or macular degradation.
for hyperglycaemia, e.g. antidiabetics · CPC title
Antioedematous agents; Diuretics · CPC title
Antineoplastic agents · CPC title
Drugs for disorders of the cardiovascular system · CPC title
for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.